Laninamivir Completed Phase 1 Trials for Flu caused by Influenza Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00995826Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958